FLUGLUCOSCAN

Опис товару

About FLUGLUCOSCAN

FLUGLUCOSCAN is a diagnostic imaging agent containing the active ingredient Fluorodeoxyglucose 18F (18F-FDG). It is used in positron emission tomography (PET) scans to visualize and assess various physiological processes, particularly glucose metabolism, in the body.

Key Benefits & Uses

• Assessment of glucose metabolism in cancer cells, allowing for the detection and monitoring of various types of cancer.
• Visualization of brain function and metabolism, particularly in the diagnosis of neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Assessment of cardiovascular disease, including the evaluation of myocardial viability and perfusion.

Active Ingredient & Action

Fluorodeoxyglucose 18F (18F-FDG) is a radiolabeled glucose analog that is taken up by cells in proportion to their glucose metabolism. In PET scans, the 18F-FDG is detected and visualized, providing a map of glucose metabolism in the body. This allows for the identification of areas of high or low glucose uptake, which can be indicative of various physiological processes.

Important Notes

FLUGLUCOSCAN should only be administered under the guidance of a qualified medical professional. It is essential to follow the recommended dosage and administration instructions to ensure safe and effective use. Additionally, patients should be advised to inform their healthcare provider of any medical conditions, allergies, or sensitivities before undergoing a PET scan with FLUGLUCOSCAN.